1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
Epidemiology
You have full text access to this OnlineOpen article
Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis
Article first published online: 19 SEP 2008
DOI: 10.1002/ijc.24011
Copyright © 2008 Wiley-Liss, Inc.
Additional Information
How to Cite
Olsen, C. M., Zens, M. S., Stukel, T. A., Sacerdote, C., Chang, Y.-M., Armstrong, B. K., Bataille, V., Berwick, M., Elwood, J. M., Holly, E. A., Kirkpatrick, C., Mack, T., Bishop, J. N., Østerlind, A., Swerdlow, A. J., Zanetti, R., Green, A. C., Karagas, M. R. and Whiteman, D. C. (2009), Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis. Int. J. Cancer, 124: 937–944. doi: 10.1002/ijc.24011
Publication History
- Issue published online: 11 DEC 2008
- Article first published online: 19 SEP 2008
- Accepted manuscript online: 19 SEP 2008 12:00AM EST
- Manuscript Accepted: 30 JUL 2008
- Manuscript Received: 12 MAY 2008
Funded by
- United States National Cancer Institute. Grant Numbers: R01-CA34382, N01-CN-05230, CA32262, CA23927, P01-CA42101, CA132188
- United States National Institute for Environmental Health Sciences. Grant Number: 5P30ES07048
- Cancer Research UK Grant. Grant Numbers: C588, A4994, C569/A5030
- Danish Cancer Society
- Danish Medical Research Council
- United Kingdom Cancer Research Campaign
- Greater Glasgow Health Board Research Support Group
- Eli Lilly and Company
- National Health and Medical Research Council of Australia (NHMRC)
- Queensland Cancer Fund
- Lions Clubs of Western Australia
- Cancer Foundation of Western Australia
- University of Sydney Medical Foundation
References
- 1,,. p53 expression and risk factors for cutaneous melanoma: a case–control study. Int J Cancer 1998; 77: 843–8.
- 2,,,,,. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95: 806–12.
- 3,. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998; 78: 276–80.
- 4,. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969–1993. Int J Epidemiol 2000; 29: 416–23.
- 5,,,,,. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001. Cancer Causes Control 2007; 18: 485–91.
- 6,,. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 69–82.
- 7,,,,,,,. Neonatal sunburn and melanoma in mice. Nature 2001; 413: 271–2.
- 8,,,,,,,,,,. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 1999; 65: 483–92.
- 9,,,,,,,,. Heritability and gene–environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J Invest Dermatol 2001; 117: 348–52.
- 10,,,,,,,,,,,. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135–47.
- 11,,,. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163: 1765–70.
- 12,,,,,,,,,. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95: 1878–90.
- 13,,,,,,,,. Etiologic factors associated with p53 immunostaining in cutaneous malignant melanoma. Int J Cancer 2005; 117: 486–93.
- 14,,,,,,,,,,,, et al. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 991–7.
- 15,,,,,,. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. J Natl Cancer Inst 1989; 81: 948–52.
- 16,,,,,. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 1992; 26: 920–6.
- 17,,,,,,,,,,,, et al. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry. Int J Cancer 1995; 62: 393–7.
- 18,,,,,,. Malignant melanoma risk factors by anatomic site: a case–control study and polychotomous logistic regression analysis. Int J Cancer 1996; 67: 636–43.
- 19,,. Risk factors for melanoma by body site. Cancer Epidemiol Biomarkers Prev 2005; 14: 1241–4.
- 20,,,,,,,. Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer 1998; 78: 8–12.
- 21,,,,. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol 2006; 126: 2106–10.
- 22,,,,,. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case–control study. Melanoma Res 2006; 16: 175–82.
- 23,,,. Two-stage methods for the analysis of pooled data. Stat Med 2001; 20: 2115–30.
- 24,,,,,,,,,,,, et al. A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use. Br J Cancer 2002; 86: 1085–92.
- 25,,,,,,,,,,,, et al. Anthropometric factors and risk of melanoma in women: a pooled analysis. Int J Cancer 2008; 122: 1100–08.
- 26,,. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 1977; 36: 804–9.
- 27,,,,,,. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case–control study. Br J Cancer 1996; 73: 1605–11.
- 28,,,,. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 1990; 19: 801–10.
- 29,,,,,,. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) 1986; 292: 1555–9.
- 30,. Hormonal factors and melanoma in women. Med J Aust 1985; 142: 446–8.
- 31,,. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 1995; 141: 943–50.
- 32,. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984; 72: 257–66.
- 33,,. Case–control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 1994; 139: 869–80.
- 34,,,,,. Skin characteristics and risk of superficial spreading and nodular melanoma (United States). Cancer Causes Control 2000; 11: 741–50.
- 35,,,. The Danish case–control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 1988; 42: 821–4.
- 36,,,. Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol 1998; 27: 751–7.
- 37,,,,,,,,,. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case–control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995; 62: 367–76.
- 38,,,,,,,,,. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995; 62: 377–81.
- 39. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995; 33: 923–36; quiz 37–40.
- 40,. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998; 78: 276–80.
- 41,,,. Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. J Invest Dermatol 2008; 128: 1340–2.
- 42. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer 2000; 85: 627–32.
- 43,,,,,,,,. Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. J Invest Dermatol 2004; 122: 423–8.
- 44,,,. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body. Br J Dermatol 1999; 140: 457–62.
- 45,,,,,,. Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol 1988; 118: 641–4.
- 46,,,. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 1993; 53: 232–6.
- 47,,. Comparison of the site distribution of melanoma in New Zealand and Canada. Int J Cancer 1997; 72: 231–5.
- 48,,,,,. Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 2003–5.
- 49,,,. The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol 2003; 48: 367–75.
- 50,,,,. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. J Am Acad Dermatol 1999; 40: 549–57.
- 51,,. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995; 33: 1000–7.
- 52. The epidemiology of melanoma. Where do we go from here? In: RichardP,GallagherJME, eds. Epidemiological aspects of cutaneous malignant melanoma. Boston: Kluwer Academic Publishers, 1994. 307–23.
- 53,,. Ultraviolet radiation acts as an independent mitogen for normal human melanocytes in culture. Pigment Cell Res 1988; 1: 397–401.
- 54,,,. UVB irradiation induces melanocyte increase in both exposed and shielded human skin. J Invest Dermatol 1989; 92: 561–64.